Literature DB >> 18267056

Cervical cancer.

Benjamin E Greer, Wui-Jin Koh, Nadeem Abu-Rustum, Michael A Bookman, Robert E Bristow, Susana Campos, Kathleen R Cho, Larry Copeland, Patricia Eifel, Warner K Huh, Wainwright Jaggernauth, Daniel S Kapp, John Kavanagh, Gary H Lipscomb, John R Lurain, Mark Morgan, Robert J Morgan, C Bethan Powell, Steven W Remmenga, R Kevin Reynolds, Angeles Alvarez Secord, William Small, Nelson Teng.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18267056     DOI： 10.6004/jnccn.2008.0003

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  5 in total

1.  Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes for adoptive immunotherapy of HPV-associated malignancies.

Authors:  Carlos A Ramos; Neeharika Narala; Gayatri M Vyas; Ann M Leen; Ulrike Gerdemann; Erich M Sturgis; Matthew L Anderson; Barbara Savoldo; Helen E Heslop; Malcolm K Brenner; Cliona M Rooney
Journal:  J Immunother       Date:  2013-01       Impact factor: 4.456

Review 2.  Current imaging strategies for the evaluation of uterine cervical cancer.

Authors:  Charis Bourgioti; Konstantinos Chatoupis; Lia Angela Moulopoulos
Journal:  World J Radiol       Date:  2016-04-28

3.  Cervical Cancer Screening in Inflammatory Bowel Disease: Who Should Be Screening?

Authors:  Anuj Chhaparia; Florence Odufalu; Mitchell Edwards; Krishna Patel; Kara Christopher; Katie Schroeder; Charlene Prather; Muhammad B Hammami
Journal:  Gastroenterology Res       Date:  2020-10-08

4.  Nomogram prediction for overall survival of patients diagnosed with cervical cancer.

Authors:  S Polterauer; C Grimm; G Hofstetter; N Concin; C Natter; A Sturdza; R Pötter; C Marth; A Reinthaller; G Heinze
Journal:  Br J Cancer       Date:  2012-08-07       Impact factor: 7.640

5.  Open-label feasibility study of pazopanib, carboplatin, and paclitaxel in women with newly diagnosed, untreated, gynaecologic tumours: a phase I/II trial of the AGO study group.

Authors:  A du Bois; I Vergote; P Wimberger; I Ray-Coquard; P Harter; L B Curtis; I Mitrica
Journal:  Br J Cancer       Date:  2012-01-12       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.